Cilastatin + Imipenem + Relebactam

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
RECARBRIOCA ES EU US
  • injection ×2 Cilastatin 500 mg + Imipenem 500 mg + Relebactam 250 mg
  • unknown Cilastatin + Imipenem + Relebactam
  • injection Cilastatin 500 mg/100 mL + Imipenem 500 mg/100 mL + Relebactam 250 mg/100 mL
Merck Sharp & Dohme B.V.
imipenem anhydrous, cilastatin, and relebactam anhydrousUS500 mg/100 mL / 250 mg/100 mLMerck Sharp & Dohme LLC
Recarbrio 500mg/500mg/250mg powder for solution for infusion vialsGB
  • injection Cilastatin 500 mg + Imipenem 500 mg + Relebactam 250 mg
Merck Sharp & Dohme (UK) Ltd
Generic Recarbrio 500mg/500mg/250mg powder for solution for infusion vialsGB500 mg / 250 mgMerck Sharp & Dohme (UK) Ltd
imipenem + cilastatina + relebactamES500 mg / 250 mgMerck Sharp & Dohme B.V.
imipenem + cilastatin + relebactamES500 mg / 250 mgMerck Sharp & Dohme B.V.
瑞必優 乾粉注射劑TW
  • injection Cilastatin + Imipenem + Relebactam
美商默沙東藥廠股份有限公司台灣分公司
RECARBRIO Powder for solution for infusionTW
  • injection Cilastatin + Imipenem + Relebactam
美商默沙東藥廠股份有限公司台灣分公司
RECARBRIO 500 mg/500 mg/250 mg, poudre pour solution pour perfusionFR
  • injection Cilastatin + Imipenem + Relebactam
MERCK SHARP & DOHME (PAYS-BAS)
レカルブリオ配合点滴静注用JP
  • injection Cilastatin + Imipenem + Relebactam
MSD

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.